/Lists

Biotech Investors & VC Firms in Europe

1049 firms in this list, with a median first check of $500K. 293 of them lead rounds. Generated from verified public data and updated continuously.

Wavemaker Partners
SingaporeSeed–Series A$100K – $2.5M
56 people
Frazier Healthcare Partners
SeattleGrowth–Late Stage$50M – $400M
103 people
Frazier Life Sciences
Palo AltoSeed–Late Stage
77 people
Catalio Capital Management, LP
New YorkSeed–Late Stage
99 people
Korea Investment Partners
SeoulSeed–Series C$3M – $10M
80 people
NFX
San FranciscoPre-Seed–Series A$250K – $5M
23 people
ARCH Venture Partners
ChicagoSeed–Series C$50K – $250M
46 people
Oak HC/FT
StamfordSeed–Growth
54 people
Baird Capital
ChicagoSeed–Growth
53 people
i5invest
San FranciscoSeed
70 people
Invus
New YorkSeed–Late Stage
94 people
Sixth Street
San FranciscoGrowth–Late Stage$50M – $2.5B
78 people
SK Capital Partners
New YorkGrowth–Late Stage
95 people
WCAS
New YorkGrowth
91 people
Paladin Capital Group
WashingtonSeed–Growth$100K – $5M
65 people
Flucas Ventures
JupiterSeed–Series A$100K – $5M
1 person
HOF Capital
New YorkPre-Seed–Growth$500K – $10M
45 people
TPG
San FranciscoGrowth–Late Stage
70 people
Sky9 Capital
SingaporePre-Seed–Growth$1M – $10M
48 people
Advent International
BostonGrowth–Late Stage$1.1B
66 people
Antler Australia
SingaporePre-Seed–Growth$260K
63 people
Versant Ventures
San FranciscoSeed–Late Stage$250K – $5M
55 people
DG Daiwa Ventures
TokyoPre-Seed–Growth
32 people
One Equity Partners
New YorkGrowth
39 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.